Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-04-23Clinical Trial Update: A Study of MDX-1106 to Treat Patients With Hepatitis C Infection [Phase 1]
A Phase 1 clinical trial evaluating MDX-1106 for hepatitis C has completed, according to the trial record sponsored by Bristol-Myers Squibb.
-
CLINICAL_TRIALS trial_result · 2010-04-08Clinical Trial Update: A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults [Phase 1]
Phase 1 pharmacokinetic study examining how telaprevir affects levels of cyclosporine and tacrolimus in healthy adults.
-
CLINICAL_TRIALS trial_result · 2010-03-31Clinical Trial Update: Antiviral Activity of AZD7295 in HCV Carriers [Phase 1]
Phase 1 study evaluating antiviral activity of AZD7295 in Hepatitis C carriers has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-26Clinical Trial Update: Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis C
A clinical trial update regarding microRNA-122 in patients with chronic Hepatitis C. No results or status details are provided.
-
CLINICAL_TRIALS research · 2010-03-18Clinical Trial Update: Hepatitis C: Grading and Staging by MR
An update on a trial exploring magnetic resonance imaging for grading and staging Hepatitis C.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-03-09Clinical Trial Update: Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy [Phase 1]
This Phase 1 trial reports safety data for low-dose tamoxifen in patients with chronic hepatitis C who failed standard therapy.
-
FDA approval · 2010-03-03FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)
FDA approved a supplemental application for PEGASYS (peginterferon alfa-2a) from pharmaand GmbH, approving an update to the biologics licens…
-
CLINICAL_TRIALS trial_result · 2010-02-22Clinical Trial Update: Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793)
This clinical trial update reports results from a completed study evaluating pegylated interferon alfa-2b (Peg-Intron) plus ribavirin (Rebet…
-
CLINICAL_TRIALS trial_result · 2010-02-19Clinical Trial Update: Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment [Phase 2, Phase 3]
Phase 2 and Phase 3 clinical trials evaluated strategies to prophylax against psychiatric symptoms in patients undergoing anti-Hepatitis C t…
-
CLINICAL_TRIALS trial_result · 2010-02-15Clinical Trial Update: Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma [Phase 4]
Phase 4 trial investigating peginterferon alfa-2a plus ribavirin in chronic hepatitis C patients with hepatocellular carcinoma; current stat…
-
CLINICAL_TRIALS research · 2010-02-10Clinical Trial Update: Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients [Phase 1, Phase 2]
A Phase I/IIa dose-ranging clinical trial of CHRONVAC-C in chronic hepatitis C virus infection; the status of the study is currently unknown…
-
CLINICAL_TRIALS trial_result · 2010-02-08Clinical Trial Update: Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides [Phase 1]
Phase I trial of a virosome-formulated peptide vaccine for chronic hepatitis C has completed the Phase I stage.
-
CLINICAL_TRIALS trial_result · 2010-02-08Clinical Trial Update: Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 Infection [Phase 4]
A Phase 4 clinical trial evaluating individually adapted therapy durations for chronic hepatitis C genotype 1 infection has completed.
-
CLINICAL_TRIALS research · 2010-01-22Clinical Trial Update: The Incidence of Occult Hepatitis C Virus Infection in Hemodialysed Patients With Liver Enzymes Disturbances
This clinical trial evaluates the incidence of occult Hepatitis C virus infection in patients on hemodialysis with disturbed liver enzyme le…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Treatment of Cholestatic Pruritus With Sertraline [Phase 2]
A Phase 2 trial evaluated sertraline for treatment of cholestatic pruritus in patients with liver disease and has completed.
-
CLINICAL_TRIALS trial_result · 2010-01-08Clinical Trial Update: Mucomyst for Hepatitis C [NA]
A clinical trial evaluating Mucomyst (acetylcysteine) for hepatitis C has been suspended.
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects [Phase 1]
A Phase 1 study assessed potential drug-drug interactions between VCH-222 and telaprevir in healthy subjects; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2010-01-06Clinical Trial Update: Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212) [Phase 4]
A Phase 4 trial in treatment-naive hepatitis C patients evaluated pegylated interferon alfa-2b (Peg-Intron) plus ribavirin (Rebetol) with a …
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation [Phase 3]
Phase 3 trial evaluating the safety and antiviral activity of tipranavir (TPV) in HIV-infected patients coinfected with hepatitis C and/or h…
-
CLINICAL_TRIALS research · 2009-12-04Clinical Trial Update: Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus
A clinical trial update studying the relationship between cytokine levels and liver histology in patients co-infected with HIV-1 and hepatit…
-
CLINICAL_TRIALS trial_result · 2009-12-01Clinical Trial Update: Multiple Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04878691 [Phase 1]
Pfizer's Phase 1 multiple-oral-dose study of PF-04878691 for hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9 [Phase 4]
Phase 4 clinical trial of Pegasys (peginterferon alfa-2a) and Copegus (ribavirin) in treatment-naive patients with chronic hepatitis C genot…
-
CLINICAL_TRIALS trial_result · 2009-11-13Clinical Trial Update: Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin [Phase 4]
Phase 4 trial update evaluating retreatment of chronic hepatitis C in dialysis patients using pegylated interferon alfa-2a plus low-dose rib…
-
CLINICAL_TRIALS trial_result · 2009-10-30Clinical Trial Update: Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471) [Phase 3]
Phase 3 trial evaluating peginterferon dose regimens in previously untreated chronic hepatitis C with genotype 1; results posted.
-
CLINICAL_TRIALS trial_result · 2009-10-20Clinical Trial Update: Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients [Phase 4]
This Phase 4 clinical trial updates the switch from didanosine to tenofovir in HIV/HCV co-infected patients, with follow-up on safety and vi…